Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.

Bibliographic Details
Title: Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Authors: Meedt, Elisabeth, Weber, Daniela, Bonifacius, Agnes, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Delecluse, Susanne, Delecluse, Henri-Jacques, Lorenz, Myriam, Schwarz, Klaus, Meedt, Stefan T, Braess, Jan, Herr, Wolfgang, Holler, Ernst, Edinger, Matthias, Wolff, Daniel
Source: Clinical Infectious Diseases; 6/15/2023, Vol. 76 Issue 12, p2200-2202, 3p
Subject Terms: TREATMENT of Epstein-Barr virus diseases, HOMOGRAFTS, GRAFT versus host disease, CHRONIC diseases, CELLS, VIREMIA, HEMATOPOIETIC stem cell transplantation, T cells, IMMUNOSUPPRESSIVE agents, DISEASE remission
Abstract: We report sustained remission of chronic active Epstein-Barr virus (EBV) infection in a 27-year-old female patient treated with third-party EBV-specific T cells followed by allogeneic hematopoietic stem cell transplantation (HSCT). The viremia cleared after administration of anti-T-lymphocyte globulin for graft-versus-host disease (GvHD) prophylaxis. Subsequent expansion of EBV-infected host T cells was controlled by transfusion of donor-derived EBV-specific T cells. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:10584838
DOI:10.1093/cid/ciad131
Published in:Clinical Infectious Diseases
Language:English